
|Articles|May 17, 2019
When to consider corneal cross-linking treatment
Author(s)Julianne Mobilian
Audrey Talley Rostov, MD, discusses corneal cross-linking (CXL) complications, and when to consider CXL treatment
Advertisement
RELATED:
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Glaukos receives FDA approval for Epioxa topical therapy for keratoconus
2
AAO 2025: Kenneth C. Fan, MD, sees vision gains with MCO-010 in Stargardt disease
3
AAO 2025: Diana Do reviews the real-world use of aflibercept 8 mg
4
Aurion Biotech releases positive 12-month results from phase 1/2 CLARA trial
5